Greater Chicago Area
Experienced Sales Executive with a demonstrated history of success in the clinical drug development and computer software industries. Skilled in a wide range of clinical services, Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Electronic Data Capture (EDC), and Medical Devices. Strong sales professional with a M.S. in Molecular Biology from University of Illinois at Chicago.
Instem is a global provider of leading IT solutions and services for the international life sciences market. Early phase clinical study management services include the ALPHADAS suite of tools. Through Instem's Submit™ tools and services, solutions are available for converting client datasets from any source into regulatory-compatible formats for managing, storing, sharing and submitting to regulatory agencies.
Schulman Associates Institutional Review Board, Inc. is an independent IRB that has more than 27 years of experience in reviewing research protocols and consent documents to evaluate compliance with relevant regulations and ethical guidelines. Schulman is dedicated to promoting clinical research by helping to safeguard the rights and welfare of clinical research subjects.
To better reflect its diverse therapeutic expertise, Comprehensive NeuroScience, Inc. (CNS), a strategic clinical research organization delivering high-quality clinical development services from early proof-of-concept through commercialization, has changed its company name to Comprehensive Clinical Development, along with its tagline, “The Proof is in the Performance.” Under its new name and tagline, Comprehensive Clinical Development will continue to deliver superior quality CRO services in partnership with sponsors who can be confident that their projects will be done correctly and on time. Comprehensive Clinical Development offers full-service capabilities and therapeutic expertise in numerous indications, including, but not limited to, CNS, dermatology, diabetes, infectious disease, obesity, and postmenopausal women, and collects early efficacy data across these populations. Offering CRO services both of developmental and clinical conduct, Comprehensive Clinical Development leverages the diversity of its service networks to provide biopharmaceutical clients with exceptional quality and cost-effective trial management. Along with early and late phase site clinical conduct, Comprehensive Clinical Development provides a full range of services from protocol writing through final clinical study reporting.
I am a Sr. Director, Business Development for Comprehensive Drug Development (CDD), a division of Comprehensive NeuroScience (CNS).